Cargando…
Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells
Nuclear factor kappa B (NF‐κB) signaling pathway is activated in many colorectal cancer (CRC) cells and in the tumor microenvironment, which plays a critical role in cancer initiation, development, and response to therapies. In the present study, we found that the widely used antimalarial drug meflo...
Autores principales: | Xu, Xin, Wang, Jun, Han, Kunkun, Li, Shaoyan, Xu, Feng, Yang, Yili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891192/ https://www.ncbi.nlm.nih.gov/pubmed/29453896 http://dx.doi.org/10.1111/cas.13540 |
Ejemplares similares
-
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria
por: Saeheng, Teerachat, et al.
Publicado: (2023) -
A Review of Modifications of Quinoline Antimalarials: Mefloquine and (hydroxy)Chloroquine
por: Kucharski, Dawid J., et al.
Publicado: (2022) -
The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism
por: Degiacomi, Giulia, et al.
Publicado: (2021) -
The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418
por: Ferguson, Michael W., et al.
Publicado: (2019) -
Nuclear factor-kappa B1 inhibits early apoptosis of glioma cells by promoting the expression of Bcl-2
por: Yang, Tian-quan, et al.
Publicado: (2017)